MedTrace Logo

Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis

NCT07319728 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-01-06

No results posted yet for this study

Summary

A single blind randomized controlled clinical study

Conditions

Interventions

DRUG

ketoprofen

new gel formulation

DRUG

ketoprofen

commercial gel

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Principal Investigators

  • Sara A Hassan · Badr University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-10
Primary Completion
2026-01-31
Completion
2026-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07319728 on ClinicalTrials.gov